QQQ   424.84 (-0.23%)
AAPL   167.31 (-0.41%)
MSFT   408.68 (-0.77%)
META   508.55 (+2.91%)
GOOGL   156.51 (+0.67%)
AMZN   181.37 (+0.05%)
TSLA   149.94 (-3.54%)
NVDA   855.17 (+1.76%)
AMD   155.66 (+1.06%)
NIO   4.01 (+2.56%)
BABA   69.12 (+0.44%)
T   16.18 (+0.37%)
F   12.07 (+0.25%)
MU   112.87 (-2.97%)
GE   156.20 (+0.34%)
CGC   7.95 (+22.50%)
DIS   113.50 (+0.50%)
AMC   2.93 (-1.68%)
PFE   25.29 (-0.51%)
PYPL   62.44 (-1.30%)
XOM   118.89 (+0.22%)
QQQ   424.84 (-0.23%)
AAPL   167.31 (-0.41%)
MSFT   408.68 (-0.77%)
META   508.55 (+2.91%)
GOOGL   156.51 (+0.67%)
AMZN   181.37 (+0.05%)
TSLA   149.94 (-3.54%)
NVDA   855.17 (+1.76%)
AMD   155.66 (+1.06%)
NIO   4.01 (+2.56%)
BABA   69.12 (+0.44%)
T   16.18 (+0.37%)
F   12.07 (+0.25%)
MU   112.87 (-2.97%)
GE   156.20 (+0.34%)
CGC   7.95 (+22.50%)
DIS   113.50 (+0.50%)
AMC   2.93 (-1.68%)
PFE   25.29 (-0.51%)
PYPL   62.44 (-1.30%)
XOM   118.89 (+0.22%)
QQQ   424.84 (-0.23%)
AAPL   167.31 (-0.41%)
MSFT   408.68 (-0.77%)
META   508.55 (+2.91%)
GOOGL   156.51 (+0.67%)
AMZN   181.37 (+0.05%)
TSLA   149.94 (-3.54%)
NVDA   855.17 (+1.76%)
AMD   155.66 (+1.06%)
NIO   4.01 (+2.56%)
BABA   69.12 (+0.44%)
T   16.18 (+0.37%)
F   12.07 (+0.25%)
MU   112.87 (-2.97%)
GE   156.20 (+0.34%)
CGC   7.95 (+22.50%)
DIS   113.50 (+0.50%)
AMC   2.93 (-1.68%)
PFE   25.29 (-0.51%)
PYPL   62.44 (-1.30%)
XOM   118.89 (+0.22%)
QQQ   424.84 (-0.23%)
AAPL   167.31 (-0.41%)
MSFT   408.68 (-0.77%)
META   508.55 (+2.91%)
GOOGL   156.51 (+0.67%)
AMZN   181.37 (+0.05%)
TSLA   149.94 (-3.54%)
NVDA   855.17 (+1.76%)
AMD   155.66 (+1.06%)
NIO   4.01 (+2.56%)
BABA   69.12 (+0.44%)
T   16.18 (+0.37%)
F   12.07 (+0.25%)
MU   112.87 (-2.97%)
GE   156.20 (+0.34%)
CGC   7.95 (+22.50%)
DIS   113.50 (+0.50%)
AMC   2.93 (-1.68%)
PFE   25.29 (-0.51%)
PYPL   62.44 (-1.30%)
XOM   118.89 (+0.22%)

Intra-Cellular Therapies (ITCI) SEC Filings & 10K Form

$73.06
-3.63 (-4.73%)
(As of 12:52 PM ET)

Recent Intra-Cellular Therapies SEC Filings

DateFilerForm TypeView
04/16/2024
3:40 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:37 PM
Intra-Cellular Therapies (Filer)
Form 424B5
04/16/2024
6:10 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
3:15 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:15 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
4:15 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:44 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
7:31 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:31 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:32 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:33 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:33 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
3:52 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:38 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:45 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:30 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:30 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/08/2024
4:58 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:58 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:58 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:59 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:59 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:44 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
3:36 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
3:27 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:04 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:05 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:05 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:05 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:41 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:57 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:58 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:58 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:59 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
7:00 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
7:00 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:22 PM
Intra-Cellular Therapies (Subject)
VAN NOSTRAND ROBERT L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:46 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:46 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:33 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:22 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.
02/22/2024
6:39 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
6:42 AM
Intra-Cellular Therapies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/09/2024
11:40 AM
Intra-Cellular Therapies (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
02/05/2024
5:02 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:05 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:07 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:10 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:13 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:47 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
3:39 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
3:41 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/18/2024
6:47 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
4:08 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
5:02 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
3:45 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
6:54 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:43 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:46 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:38 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
10:15 AM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:52 PM
Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2023
4:31 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
3:15 PM
Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
12:06 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/02/2023
7:01 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
7:01 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2023
4:29 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
4:30 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
7:40 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
3:13 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2023
3:13 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:18 PM
Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
3:40 PM
Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2023
5:05 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
5:09 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2023
6:39 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
6:44 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/20/2023
4:47 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2023
3:13 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/07/2023
5:07 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4/A
07/07/2023
5:07 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4/A
07/07/2023
5:08 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4/A
07/05/2023
3:30 PM
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:30 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:11 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:11 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:12 PM
Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:12 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:05 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
3:28 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.
05/04/2023
6:45 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2023
6:37 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2023
5:00 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ITCI) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners